Denis Chem Lab Ltd
Incorporated in 1982, Denis Chem Lab Ltd does manufacturing of Pharmaceuticals Transfusion Solution in Bottles[1]
- Market Cap ₹ 137 Cr.
- Current Price ₹ 98.8
- High / Low ₹ 193 / 88.0
- Stock P/E 16.2
- Book Value ₹ 61.3
- Dividend Yield 1.52 %
- ROCE 13.9 %
- ROE 9.77 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 30.7%
Cons
- The company has delivered a poor sales growth of 5.03% over past five years.
- Promoter holding is low: 39.0%
- Company has a low return on equity of 11.9% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
67 | 75 | 98 | 112 | 107 | 123 | 135 | 109 | 136 | 161 | 167 | 173 | 175 | |
60 | 66 | 89 | 98 | 95 | 110 | 120 | 99 | 122 | 142 | 146 | 157 | 159 | |
Operating Profit | 6 | 9 | 8 | 14 | 12 | 14 | 15 | 10 | 14 | 19 | 21 | 16 | 17 |
OPM % | 9% | 12% | 9% | 12% | 11% | 11% | 11% | 9% | 11% | 12% | 13% | 9% | 9% |
0 | 0 | 0 | 1 | 1 | 2 | 0 | 0 | 1 | 1 | 1 | 2 | 2 | |
Interest | 3 | 5 | 7 | 6 | 5 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 1 |
Depreciation | 1 | 4 | 6 | 7 | 6 | 6 | 7 | 6 | 6 | 8 | 7 | 7 | 7 |
Profit before tax | 2 | 0 | -3 | 2 | 2 | 6 | 6 | 3 | 9 | 11 | 15 | 11 | 12 |
Tax % | 41% | 78% | 30% | 37% | -5% | -7% | 26% | 27% | 30% | 28% | 26% | 27% | |
1 | 0 | -4 | 1 | 2 | 6 | 4 | 2 | 6 | 8 | 11 | 8 | 8 | |
EPS in Rs | 1.17 | 0.07 | -4.16 | 0.89 | 1.54 | 4.58 | 3.03 | 1.63 | 4.51 | 5.66 | 8.04 | 5.82 | 6.11 |
Dividend Payout % | -0% | -0% | -0% | -0% | -0% | 22% | -0% | 46% | 33% | 35% | 31% | 26% |
Compounded Sales Growth | |
---|---|
10 Years: | 9% |
5 Years: | 5% |
3 Years: | 8% |
TTM: | 5% |
Compounded Profit Growth | |
---|---|
10 Years: | 59% |
5 Years: | 14% |
3 Years: | 9% |
TTM: | -20% |
Stock Price CAGR | |
---|---|
10 Years: | 14% |
5 Years: | 18% |
3 Years: | 8% |
1 Year: | -41% |
Return on Equity | |
---|---|
10 Years: | 8% |
5 Years: | 10% |
3 Years: | 12% |
Last Year: | 10% |
Balance Sheet
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3 | 9 | 9 | 12 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
Reserves | 6 | 8 | 7 | 18 | 36 | 43 | 45 | 48 | 53 | 58 | 66 | 71 |
31 | 48 | 44 | 37 | 25 | 23 | 14 | 9 | 3 | 2 | 1 | 1 | |
12 | 17 | 24 | 27 | 26 | 26 | 25 | 22 | 27 | 25 | 28 | 26 | |
Total Liabilities | 52 | 81 | 85 | 94 | 101 | 106 | 97 | 92 | 96 | 99 | 109 | 112 |
9 | 42 | 40 | 44 | 40 | 50 | 46 | 41 | 42 | 35 | 38 | 39 | |
CWIP | 9 | 0 | 10 | 1 | 5 | 0 | -0 | 0 | -0 | 2 | 0 | 0 |
Investments | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
34 | 39 | 35 | 49 | 56 | 55 | 52 | 51 | 55 | 62 | 72 | 73 | |
Total Assets | 52 | 81 | 85 | 94 | 101 | 106 | 97 | 92 | 96 | 99 | 109 | 112 |
Cash Flows
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-2 | 14 | 21 | 7 | 11 | 8 | 13 | 8 | 17 | 16 | 18 | 12 | |
-9 | -28 | -13 | -1 | -16 | -2 | -2 | -1 | -10 | -11 | -15 | -8 | |
12 | 13 | -7 | -0 | 1 | -5 | -14 | -6 | -7 | -4 | -4 | -4 | |
Net Cash Flow | 0 | -1 | 1 | 5 | -4 | 1 | -3 | 1 | -0 | 1 | -1 | -0 |
Ratios
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 91 | 123 | 85 | 104 | 105 | 106 | 94 | 110 | 85 | 71 | 69 | 65 |
Inventory Days | 37 | 40 | 39 | 35 | 52 | 50 | 51 | 60 | 50 | 39 | 43 | 37 |
Days Payable | 53 | 81 | 119 | 136 | 150 | 102 | 108 | 103 | 99 | 79 | 90 | 81 |
Cash Conversion Cycle | 75 | 81 | 4 | 3 | 8 | 55 | 37 | 67 | 36 | 31 | 22 | 21 |
Working Capital Days | 32 | -19 | -57 | -13 | 4 | 17 | 32 | 63 | 51 | 41 | 37 | 38 |
ROCE % | 16% | 11% | 5% | 12% | 9% | 11% | 11% | 6% | 14% | 16% | 20% | 14% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
26 Aug - Clipping of Newspaper Advertisement for 44th AGM of the Company Published on 26th August, 2025
-
Announcement Under Regulation 30 (LODR) - Notice Of 44Th AGM Alongwith Annual Report 2024-25.
25 Aug - AGM on 26 Sep 2025; recommended final dividend Rs.1.50/share; Annual Report filed; cost auditor fee Rs.1,70,000.
- Shareholders Meeting - Annual Report 2024-25 Alongwith Notice Of 44Th AGM. 25 Aug
-
Reg. 34 (1) Annual Report.
25 Aug - 44th AGM on 26 Sep 2025; final dividend Rs.1.50/share; auditors appointments; director continuation resolution.
- Results- Financial Results For June, 30, 2025 13 Aug
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
DCLL manufactures and markets sterile Intravenous injectibles in Glass and Plastic Bottles for human and veterinary consumption. It also manufactures products on contract basis for multinational pharmaceutical companies who market them under their own brands. Company has a fully equipped in-house Quality Control Laboratory having different interdepartments for Chemical Testing, Physico-Chemical Testing, Microbiological Testing, Pyrogens Testing, Sterility Testing and Toxicity Testing. All raw materials, packaging materials, in process testing and finished stocks are tested in-house.